8-A12B 1 tm2128805d1_8a12b.htm 8-A12B

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

MONTEREY BIO ACQUISITION CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   85-2204842
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
17 State Street, 21st Floor, New York, NY   10004
(Address of Principal Executive Offices)   (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class to be Registered

 

Name of Each Exchange on Which Each Class is to be Registered

     
Units, each consisting of one share of Common Stock and one Warrant   The Nasdaq Stock Market LLC
     
Common Stock, par value $0.0001 per share   The Nasdaq Stock Market LLC
     

Warrants, each warrant exercisable for one share of Common Stock at

an exercise price of $11.50

 

The Nasdaq Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box.  x

     

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.  ¨

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

 

Securities Act registration statement file number to which this form relates:   333-259378  
    (If applicable)  

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

N/A
(Title of Class)

 

 

 

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The securities to be registered hereby are the units, common stock, par value $0.0001 per share, and warrants to purchase shares of common stock of Monterey Bio Acquisition Corporation (the “Company”). The description of the units, common stock and warrants contained in the section entitled “Description of Securities” in the prospectus included in the Company’s Registration Statement on Form S-1 (File No. 333-259378) filed with the Securities and Exchange Commission on September 7, 2021, as amended from time to time (the “Registration Statement”), to which this Form 8-A relates, is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is also incorporated by reference herein.

 

Item 2. Exhibits.

 

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed, because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  MONTEREY BIO ACQUISITION CORPORATION
     
  By:   /s/ Sanjeev Satyal
    Name:  Sanjeev Satyal
    Title: Chief Executive Officer

 

Dated: September 30, 2021